Urticaria paradoxically aggraved by H1 antihistamines;Urticaires paradoxalement aggravées par les antihistaminiques H1

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 5, 2004, Pages 451-453

  Catelain, A ^a,b   Freymond, N ^a   Queuille, E ^a   Nicolas, J F ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; DEXCHLORPHENIRAMINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; MONTELUKAST;

ADULT; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; INTRACUTANEOUS TEST; MALE; MAST CELL; PRICK TEST; RASH; URTICARIA;

EID: 2942699983     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(04)93638-1     Document Type: Article

References (19)

1. Conférence de consensus: Prise en charge de l'urticaire chronique. Ann Dermatol Venereol 2003;130 (suppl 1):1S74-1S81.
2. Craig-McFeely PM, Acharya NV, Shakir SA. Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997. Eur J Clin Pharmacol 2001;57:313-20.
3. Finn AF Jr, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCL in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999;104:1071-8.
4. Breneman D, Bronsky EA, Kalivas JT, Klein GL, Roth HL, Tharp MD, Treger C, Soter N. Cetirizine and astemizole therapy for chronique idiopathic urticaria: a double-blind, placebo controlled, comparative trial. J Am Acad Dermatol 1995;33:192-8.
5. Ring J, Hein R, Gauger A. Desloratadine: a new approach in the treatment of allergy as a systemic disease-pharmacology and clinical overview. Allergy 2001;56:28-32.
6. Hein R. Chronic urticaria: impact of allergic inflammation. Allergy 2002;57:19-24.
7. Greaves MW. Chronic urticaria. N Engl J Med 1995;332:1767-72.
8. Karamfilov T, Wilmer A, Hipler UC, Wollina U. Cetirizine-induced urticarial reaction. Br J Dermatol 1999;140:979-80.
9. Tella R, Gaig P, Bartra J, Garcia-Ortega P. Urticaria to cetirizine. J Invest Allergol Clin Immunol 2002;12;136-7.
10. Schroter S, Damveld B, Marsch WC. Urticarial intolerance reaction to cetirizine. Clin Exp Dermatol 2002;27:185-7.
11. Calista D, Schianchi S, Morri M. Urticaria induced by cetirizine. Br J Dermatol 2001;144:196.
12. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002;110:484-8.
13. Eymard B, Cousin F, Nicolas JF. Prévention d'un angio-oedème à l'aspirine par l'association antileucotriè ne/antihistaminique. Ann Dermatol Venereol 2004;in press.
14. Saint-Mézard P, Bosset S, Cousin F, Ionescu MA, Nicolas JF. Mastocytes et peau. Rev Fr Allergol Immunol Clin 2002;42:193-8.
15. Bérard F, Saint-Mézard P, Cousin F, Mécheri S, Nicolas JF. Mécanismes immunologiques des urticaires. Conférence de consensus urticaire chronique. Ann Dermatol Venereol 2003;130 (Suppl 1):1S10-1S15.
16. Cousin F, Catelain A, Philips K, Favier B, Nicolas JF. L'hypersensibilité immédiate est rarement en cause dans les urticaires médicamenteuses. Ann Dermatol Venereol 2003;130:321-4.
17. Cousin F, Philips K, Favier B, Bienvenu J, Nicolas JF. Drug-induced urticaria. Eur J Dermatol 2001;11:181-7.
18. Cousin F, Catelain A, Philips K, Favier B, Nicolas JF. L'urticaire chronique idiopathique favorise l'urticaire médicamenteuse pseudoallergique. Ann Dermatol Venereol 2001;128:3S1-77.
19. Mansini E, Blandina P, Mannaionni PF. Mast cell receptor controlling histamine release: influence on the mode of action of drugs used in the treatment of adverse drug reactions. Klin Wochenschr 1982;60:1031-8.